Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 5 days agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 7 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 5 days agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 6 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 5 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 4 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared ...
Why 93% Of This Biotech's Value Just Went Up In Smoke
Investor's Business Daily· 1 day agoWedbush analyst Laura Chico slashed her price target on Aerovate stock to 3 from 41, calling the...